CTRI Number |
CTRI/2025/04/085519 [Registered on: 24/04/2025] Trial Registered Prospectively |
Last Modified On: |
22/04/2025 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Ayurveda |
Study Design |
Randomized, Parallel Group Trial |
Public Title of Study
|
Ayurvedic management for BPH |
Scientific Title of Study
|
Comparative clinical study to evaluate the efficacy of Dashmool Sidha Taila Uttar Basti and Matra Basti in the management of Vat Ashthila wsr to Benign Prostate Hyperplasia (BPH) |
Trial Acronym |
NIL |
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Pratibha Ola |
Designation |
PG Scholar |
Affiliation |
Madan Mohan Malviya Government Ayurved College Udaipur Rajasthan |
Address |
PG Scholar
PG Department of Shalya Tantra
Madan Mohan Malviya Government Ayurved College Udaipur Rajasthan
Udaipur RAJASTHAN 313001 India |
Phone |
8005696012 |
Fax |
|
Email |
pratibhaola11@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Namo Narayan Meena |
Designation |
Associate Professor |
Affiliation |
Madan Mohan Malviya Government Ayurved College Udaipur Rajasthan |
Address |
Associate Professor
PG Department of Shalya Tantra
Madan Mohan Malviya Government Ayurved College Udaipur Rajasthan
Udaipur RAJASTHAN 313001 India |
Phone |
9928871125 |
Fax |
|
Email |
drnamorajat@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Namo Narayan Meena |
Designation |
Associate Professor |
Affiliation |
Madan Mohan Malviya Government Ayurved College Udaipur Rajasthan |
Address |
Associate Professor
PG Department of Shalya Tantra
Madan Mohan Malviya Government Ayurved College Udaipur Rajasthan
Udaipur RAJASTHAN 313001 India |
Phone |
9928871125 |
Fax |
|
Email |
drnamorajat@gmail.com |
|
Source of Monetary or Material Support
|
Madan Mohan Malviya Government Ayurved College Udaipur Rajasthan India PIN 313001 |
|
Primary Sponsor
|
Name |
Madan Mohan Malviya Government Ayurved College Udaipur Rajasthan |
Address |
Rada ji Circle Ambamata scheme Udaipur Rajasthan PIN 313001 |
Type of Sponsor |
Government medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Pratibha Ola |
Madan Mohan Malviya Government Ayurved College Udaipur Rajasthan |
OPD No 1 and 8
PG Department of Shalya Tantra
Associated group of Hospitals Madan Mohan Malviya Government Ayurved College Udaipur Rajasthan Udaipur RAJASTHAN |
8005696012
pratibhaola11@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethics Committee Madan Mohan Malviya Government Ayurved College Udaipur Rajasthan |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition:N400||Benign prostatic hyperplasia without lower urinary tract symptoms. Ayurveda Condition: VATASHTHILA, |
|
Intervention / Comparator Agent
|
sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | 1 | Intervention Arm | Procedure | - | mAtrAbastiH, मात्राबस्तिः | (Procedure Reference: Charaka Samhita, Procedure details: Matra Basti will be given for 7 days followed by a gap of one week
Same procedure will be repeated up to 4 weeks) (1) Medicine Name: Dashmool Sidha Taila, Reference: Sushruta Samhita, Route: Rectal, Dosage Form: Taila, Dose: 30(ml), Frequency: od, Duration: 4 Weeks | 2 | Comparator Arm | Procedure | - | uttara-bastiH, उत्तर-बस्तिः | (Procedure Reference: Charaka Samhita, Procedure details: Uttar Basti will be given for 7 days followed by a gap of one week
Same procedure will be repeated up to 4 weeks) (1) Medicine Name: Dashmool Sidha Taila, Reference: Sushruta Samhita, Route: Urethral, Dosage Form: Taila, Dose: 30(ml), Frequency: od, Duration: 4 Weeks |
|
|
Inclusion Criteria
|
Age From |
40.00 Year(s) |
Age To |
75.00 Year(s) |
Gender |
Male |
Details |
1) Patients suffering from sign and symptoms of Benign Prostate Hyperplasia
2) Residual urine should be less than 120 ml
2) Size of Prostate less than 40 cc |
|
ExclusionCriteria |
Details |
1) Patients suffering from Uncontrolled Diabetes Mellitus Tuberculosis Hepatitis Prostatitis and Malignancy
2) Residual urine greater than 120 ml
3) Size of Prostate greater than 40 cc
4) Catheterized patients |
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
An Open list of random numbers |
Blinding/Masking
|
Participant Blinded |
Primary Outcome
|
Outcome |
TimePoints |
1) Improvement in sign and symptoms of Benign Prostate Hyperplasia
2) Reduction in size of Prostate
3) Residual urine volume |
28 days |
|
Secondary Outcome
|
Outcome |
TimePoints |
1) Improvement in sign and symptoms of Benign Prostate Hyperplasia
2) Recurrence of Benign Prostate Hyperplasia |
1 month |
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 2 |
Date of First Enrollment (India)
|
01/07/2025 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="0" Months="2" Days="0" |
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
N/A |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
This is an open labelled parallel group study. In this study, group A 30 patients will be administered with Dashmool Sidha Taila Uttar Basti for 7 days followed by a gap of 1 week for 28 days and group B 30 patients will be administered with Dashmool Sidha Taila Matra Basti for 7 days followed by a gap of 1 week for 28 days |